Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$GILD Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$8.45 down -638.22% YoY
• Reported revenue of $7.8B up 10.18% YoY
• Gilead Sciences, Inc. now expects full year 2026 product sales between $30.1 billion and $30.4 billion, with diluted loss per share between $(3.75) and $(3.40) and non-GAAP diluted loss per share between $(0.65) and $(0.30).1
